APPLICATIONS OF PLASMA MITOCHONDRIAL DNA ANALYSIS

    公开(公告)号:EP4418274A2

    公开(公告)日:2024-08-21

    申请号:EP24186490.9

    申请日:2016-01-13

    IPC分类号: G16B20/00

    摘要: An amount of mitochondrial DNA molecules relative to an amount of nuclear DNA molecules is determined in a biological sample, and the relative amount is used for various purposes, e.g., screening, detection, prognostication or monitoring of various physiological and pathological conditions. As examples, an amount of mitochondrial DNA can be used to estimate a concentration of DNA of a tissue type, such as a fetal DNA concentration, tumor DNA concentration, or a concentration of DNA in the biological sample derived from a non-hematopoietic tissue source. Sequencing techniques can be used to determine a mitochondrial DNA concentration in a sample for an accurate detection of a level of cancer. A level of an auto-immune disease is also determined using a relative amount of mitochondrial DNA molecules compared nuclear DNA molecules.

    NON-INVASIVE DETERMINATION OF METHYLOME OF TUMOR FROM PLASMA

    公开(公告)号:EP4056712A1

    公开(公告)日:2022-09-14

    申请号:EP22171427.2

    申请日:2013-09-20

    IPC分类号: C12Q1/68 C12Q1/6869

    摘要: Systems, methods, and apparatuses can determine and use methylation profiles of various tissues and samples. Examples are provided. A methylation profile can be deduced for fetal/tumor tissue based on a comparison of plasma methylation (or other sample with cell-free DNA) to a methylation profile of the mother/patient. A methylation profile can be determined for fetal/tumor tissue using tissue-specific alleles to identify DNA from the fetus/tumor when the sample has a mixture of DNA. A methylation profile can be used to determine copy number variations in genome of a fetus/tumor. Methylation markers for a fetus have been identified via various techniques. The methylation profile can be determined by determining a size parameter of a size distribution of DNA fragments, where reference values for the size parameter can be used to determine methylation levels. Additionally, a methylation level can be used to determine a level of cancer.

    APPLICATIONS OF PLASMA MITOCHONDRIAL DNA ANALYSIS
    9.
    发明公开
    APPLICATIONS OF PLASMA MITOCHONDRIAL DNA ANALYSIS 审中-公开
    等离子体线粒体DNA分析的应用

    公开(公告)号:EP3245300A1

    公开(公告)日:2017-11-22

    申请号:EP16737076.6

    申请日:2016-01-13

    IPC分类号: C12Q1/68

    摘要: An amount of mitochondrial DNA molecules relative to an amount of nuclear DNA molecules is determined in a biological sample, and the relative amount is used for various purposes, e.g., screening, detection, prognostication or monitoring of various physiological and pathological conditions. As examples, an amount of mitochondrial DNA can be used to estimate a concentration of DNA of a tissue type, such as a fetal DNA concentration, tumor DNA concentration, or a concentration of DNA in the biological sample derived from a non-hematopoietic tissue source. Sequencing techniques can be used to determine a mitochondrial DNA concentration in a sample for an accurate detection of a level of cancer. A level of an auto-immune disease is also determined using a relative amount of mitochondrial DNA molecules compared nuclear DNA molecules.

    SEQUENCING ANALYSIS OF CIRCULATING DNA TO DETECT AND MONITOR AUTOIMMUNE DISEASES
    10.
    发明公开
    SEQUENCING ANALYSIS OF CIRCULATING DNA TO DETECT AND MONITOR AUTOIMMUNE DISEASES 审中-公开
    SEQUENZIERUNGSANALYSE VON ZIRKULIERENDER DNA ZUM NACHWEIS UND ZURÜBERWACHUNGVON AUTOIMMUNKRANKHEITEN

    公开(公告)号:EP3047038A1

    公开(公告)日:2016-07-27

    申请号:EP14845937.3

    申请日:2014-09-20

    IPC分类号: C12Q1/68

    摘要: Systems, methods, and apparatuses are provided for diagnosing auto-immune diseases such as systemic lupus erythematosus (SLE) based on the sizes, methylation levels, and/or genomic characteristics of circulating DNA molecules. Patients provide blood or other tissue samples containing cell-free nucleic molecules for analysis. Massively parallel and/or methylation-aware sequencing can be used to determine the sizes and methylation levels of individual DNA molecules and identify the number of molecules originating from different genomic regions. A level of SLE can be estimated based on: the amount of molecules having sizes below a threshold value; the methylation level(s) of the entire genome or portions of the genome; correlations between the sizes and methylation levels of DNA molecules; and/or comparing the representation of DNA molecules in each of a plurality of genomic regions with a reference value for that region, and determining an amount of genomic regions having increased or decreased measured genomic representation.

    摘要翻译: 基于循环DNA分子的大小,甲基化水平和/或基因组特征,提供系统,方法和装置用于诊断诸如系统性红斑狼疮(SLE)的自身免疫性疾病。 患者提供含有无细胞核酸分子的血液或其他组织样本用于分析。 可以使用大规模平行和/或甲基化感知测序来确定个体DNA分子的大小和甲基化水平,并确定源于不同基因组区域的分子数。 可以基于以下尺寸估计SLE的水平:具有低于阈值的分子的量; 整个基因组或基因组部分的甲基化水平; DNA分子的大小和甲基化水平之间的相关性; 和/或将多个基因组区域中的每一个中的DNA分子的表示与该区域的参考值进行比较,以及确定具有增加或减少的测量的基因组表达的基因组区域的量。